Psychoeducational Groups for Adults With ADHD

Not Applicable

Completed

• Conditions: Attention Deficit Hyperactivity Disorder
• Interventions: Behavioral: Waiting list; Behavioral: Psychoeducational group therapy; Other: Standard treatment

• Registration Number: NCT03337425
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

This pilot study aims to assess patient satisfaction and preliminary efficacy of a psychoeducational group treatment, using a randomized waitlist-controlled trial, at two different outpatient clinics in mid-Norway. All participants will receive standard treatment during the intervention period. Assessment of client satisfaction (CSQ 8), general self-efficacy (GSE-6), ADHD-related quality of life (AAQoL) symptoms of ADHD (SCL-9; ASRS), and work participation will be conducted at time of recruitment prior to randomization (T0), pre- (T1), post-treatment (T2), with a 10 week follow-up.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-11-02
• Study First Submitted QC: 2017-11-06
• Study First Posted: 2017-11-09
• Study Start: 2017-11-15
• Primary Completion: 2019-06-15
• Study Completion: 2019-06-15
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-14
• Last Update Posted: 2020-07-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

• confirmed ADHD diagnosis
• speaking a Scandinavian language

Exclusion Criteria

• not able or willing to give informed consent
• psychosis
• severe learning difficulties

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Waiting list	Waiting list	Waiting list and standard treatment (ADHD treatment as usual)
Waiting list	Standard treatment	Waiting list and standard treatment (ADHD treatment as usual)
psychoeducational groups	Psychoeducational group therapy	Psychoeducational group therapy and standard treatment (ADHD treatment as usual)
psychoeducational groups	Standard treatment	Psychoeducational group therapy and standard treatment (ADHD treatment as usual)

Primary Outcome Measures

Name	Time	Method
Change in patient satisfaction	Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)	Measured with a modified version of the Client Satisfaction Questionnaire (CSQ-8). The scale consists of 8 items measured on a scale from 1 to 4. A sum score between 8 and 32 indicate the level of satisfaction with services provided.
Change in general self-efficacy	Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)	Measured with General Self-Efficacy Scale (GSE-6), a short-form measure of self-efficacy. Self-efficacy is regarded as a protective factor in adapting to stress and chronic illness. The scale consists of 6 items, measured on a 4-point scale, with a possible range of 6-24.

Secondary Outcome Measures

Name	Time	Method
Change in ADHD-related symptoms (ASRS)	Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)	Measured with ASRS, a self-reporting scale for ADHD-related symptoms in adults. The scale consists of 18 items, based on DSM-V diagnostic criteria for ADHD. The items are measured on a 5-point scale, with a possible range of 0-72.
Change in ADHD-related symptoms (SCL-9)	Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)	Measured with 9 items from the SCL-90. SCL-9 is an ADHD-specific scale, consisting of 9 items of the original 90. SCL-9 covers the specific characteristic traits of ADHD.
Change in ADHD-related quality of life	Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)	Measured with AAQoL - which covers ADHD-specific quality of life and function. AAQoL consists of 29 questions measuring health related quality of life among adults with ADHD.

Trial Locations

Locations (2)

Tiller DPS - St. Olavs University Hospital; 🇳🇴 Trondheim, S-T, Norway

Levanger Hospital, Nord-Trøndelag Hospital Trust; 🇳🇴 Levanger, N-T, Norway